Research output per year
Research output per year
Search results
-
2020
Utility of high-throughput sequencing of T-cell receptor rearrangements in assessing treatment response in patients with mature T-cell lymphoma
Phull, P. M., Tan, C. R., Fung, H. C., Fields, P. A., Liu, Y., Zain, J., Fowler, N. H., Alpaugh, R. K., Oki, Y. & Barta, S. K., Dec 2020, In: Precision Cancer Medicine. 3, December, 31.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
2015
A phase 1 dose-escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma
Kumar, A., Blum, K. A., Fung, H. C., Smith, M. R., Foster, P. A. & Younes, A., Mar 1 2015, In: British Journal of Haematology. 168, 6, p. 902-904 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access10 Scopus citations -
2014
Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma
Goy, A., Berger, M., Ford, P., Feldman, T., Mato, A., Bejot, C. & Fung, H. C., Dec 1 2014, In: Leukemia and Lymphoma. 55, 12, p. 2932-2934 3 p.Research output: Contribution to journal › Letter › peer-review
10 Scopus citations -
2011
High-dose chemotherapy with autologous stem cell rescue for relapse after allo-SCT in multiple myeloma
Tuncer, H. H., Gregory, S. A. & Fung, H. C., Aug 2011, In: Bone Marrow Transplantation. 46, 8, p. 1156-1157 2 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
2001
Is there an association between total-body irradiation and secondary acute myelogenous leukemia/myelodysplastic syndrome in patients with relapsed/refractory Hodgkin's disease treated with autologous stem-cell transplantation? [2] (multiple letters)
Fung, H. C., Nademanee, A. P., Bhatia, S., Forman, S. J., Sureda, A. & Conde, E., Aug 1 2001, In: Journal of Clinical Oncology. 19, 15, p. 3585-3588 4 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations